141 related articles for article (PubMed ID: 35194440)
1. The miR-142 Suppresses U-87 Glioblastoma Cell Growth by Targeting EGFR Oncogenic Signaling Pathway.
Gheidari F; Arefian E; Jamshidi Adegani F; Fallah Atanaki F; Soleimani M
Iran J Pharm Res; 2021; 20(4):202-212. PubMed ID: 35194440
[TBL] [Abstract][Full Text] [Related]
2. miR-424 induces apoptosis in glioblastoma cells and targets AKT1 and RAF1 oncogenes from the ERBB signaling pathway.
Gheidari F; Arefian E; Adegani FJ; Kalhori MR; Seyedjafari E; Kabiri M; Teimoori-Toolabi L; Soleimani M
Eur J Pharmacol; 2021 Sep; 906():174273. PubMed ID: 34153339
[TBL] [Abstract][Full Text] [Related]
3. The miR-429 suppresses proliferation and migration in glioblastoma cells and induces cell-cycle arrest and apoptosis via modulating several target genes of ERBB signaling pathway.
Gheidari F; Arefian E; Saadatpour F; Kabiri M; Seyedjafari E; Teimoori-Toolabi L; Soleimani M
Mol Biol Rep; 2022 Dec; 49(12):11855-11866. PubMed ID: 36219319
[TBL] [Abstract][Full Text] [Related]
4. miR-548x and miR-4698 controlled cell proliferation by affecting the PI3K/AKT signaling pathway in Glioblastoma cell lines.
Kalhori MR; Arefian E; Fallah Atanaki F; Kavousi K; Soleimani M
Sci Rep; 2020 Jan; 10(1):1558. PubMed ID: 32005873
[TBL] [Abstract][Full Text] [Related]
5. The effect of miR-579 on the PI3K/AKT pathway in human glioblastoma PTEN mutant cell lines.
Kalhori MR; Irani S; Soleimani M; Arefian E; Kouhkan F
J Cell Biochem; 2019 Oct; 120(10):16760-16774. PubMed ID: 31243804
[TBL] [Abstract][Full Text] [Related]
6. CircABCC3 knockdown inhibits glioblastoma cell malignancy by regulating miR-770-5p/SOX2 axis through PI3K/AKT signaling pathway.
Zhang H; Xu W
Brain Res; 2021 Aug; 1764():147465. PubMed ID: 33811842
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-34b/c suppresses uveal melanoma cell proliferation and migration through multiple targets.
Dong F; Lou D
Mol Vis; 2012; 18():537-46. PubMed ID: 22419847
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-566 activates EGFR signaling and its inhibition sensitizes glioblastoma cells to nimotuzumab.
Zhang KL; Zhou X; Han L; Chen LY; Chen LC; Shi ZD; Yang M; Ren Y; Yang JX; Frank TS; Zhang CB; Zhang JX; Pu PY; Zhang JN; Jiang T; Wagner EJ; Li M; Kang CS
Mol Cancer; 2014 Mar; 13():63. PubMed ID: 24650032
[TBL] [Abstract][Full Text] [Related]
9. Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer.
Juanpere N; Agell L; Lorenzo M; de Muga S; López-Vilaró L; Murillo R; Mojal S; Serrano S; Lorente JA; Lloreta J; Hernández S
Hum Pathol; 2012 Oct; 43(10):1573-82. PubMed ID: 22417847
[TBL] [Abstract][Full Text] [Related]
10. Good or not good: Role of miR-18a in cancer biology.
Kolenda T; Guglas K; Kopczyńska M; Sobocińska J; Teresiak A; Bliźniak R; Lamperska K
Rep Pract Oncol Radiother; 2020; 25(5):808-819. PubMed ID: 32884453
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-135a regulates NHE9 to inhibit proliferation and migration of glioblastoma cells.
Gomez Zubieta DM; Hamood MA; Beydoun R; Pall AE; Kondapalli KC
Cell Commun Signal; 2017 Dec; 15(1):55. PubMed ID: 29268774
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-193a-5p exerts a tumor suppressor role in glioblastoma via modulating NOVA1.
Jin L; Li H; Wang J; Lin D; Yin K; Lin L; Lin Z; Lin G; Wang H; Ying X; Wang L; Zhang Y; Teng L
J Cell Biochem; 2019 Apr; 120(4):6188-6197. PubMed ID: 30304561
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/PI3K/Akt pathway.
Han J; Yu J; Dai Y; Li J; Guo M; Song J; Zhou X
Bosn J Basic Med Sci; 2019 Feb; 19(1):52-59. PubMed ID: 29924958
[TBL] [Abstract][Full Text] [Related]
14. Concurrent Targeting of KRAS and AKT by MiR-4689 Is a Novel Treatment Against Mutant KRAS Colorectal Cancer.
Hiraki M; Nishimura J; Takahashi H; Wu X; Takahashi Y; Miyo M; Nishida N; Uemura M; Hata T; Takemasa I; Mizushima T; Soh JW; Doki Y; Mori M; Yamamoto H
Mol Ther Nucleic Acids; 2015 Mar; 4(3):e231. PubMed ID: 25756961
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway.
Pei Q; Liu GS; Li HP; Zhang Y; Xu XC; Gao H; Zhang W; Li T
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9871-9881. PubMed ID: 31799655
[TBL] [Abstract][Full Text] [Related]
16. miR-7 inhibits glioblastoma growth by simultaneously interfering with the PI3K/ATK and Raf/MEK/ERK pathways.
Liu Z; Jiang Z; Huang J; Huang S; Li Y; Yu S; Yu S; Liu X
Int J Oncol; 2014 May; 44(5):1571-80. PubMed ID: 24603851
[TBL] [Abstract][Full Text] [Related]
17. Growth of glioblastoma is inhibited by miR-133-mediated EGFR suppression.
Xu F; Li F; Zhang W; Jia P
Tumour Biol; 2015 Dec; 36(12):9553-8. PubMed ID: 26138587
[TBL] [Abstract][Full Text] [Related]
18. MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway.
Luo X; Dong J; He X; Shen L; Long C; Liu F; Liu X; Lin T; He D; Wei G
Biomed Pharmacother; 2020 May; 125():109880. PubMed ID: 32004974
[TBL] [Abstract][Full Text] [Related]
19. Neurotensin signaling stimulates glioblastoma cell proliferation by upregulating c-Myc and inhibiting miR-29b-1 and miR-129-3p.
Ouyang Q; Chen G; Zhou J; Li L; Dong Z; Yang R; Xu L; Cui H; Xu M; Yi L
Neuro Oncol; 2016 Feb; 18(2):216-26. PubMed ID: 26180082
[TBL] [Abstract][Full Text] [Related]
20. microRNA-181a mediates the chemo-sensitivity of glioblastoma to carmustine and regulates cell proliferation, migration, and apoptosis.
Rezaei T; Hejazi M; Mansoori B; Mohammadi A; Amini M; Mosafer J; Rezaei S; Mokhtarzadeh A; Baradaran B
Eur J Pharmacol; 2020 Dec; 888():173483. PubMed ID: 32810491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
